Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status
Clinical trial NCT02339532 · COMPLETED
Trial details
- NCT number
- NCT02339532
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2019-10-07
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.